XEOMIN BETHESDA | WASHINGTON DC | FAIRFAX |
Botox, Xeomin and Dysport are classified as neurotoxins. They offer temporary
wrinkle relief most efficiently in the upper third of the face (forehead, eyebrows and eyelids) for
upwards of 3-5 months.In the greater
Washingtion D.C. Virginia, Maryland area, our practice boasts the longest clinical experience with
facial botox, dating back to 1983. Dr. Perman was a member of the clinical investigation group at
UCLA Medical Center when oculinum toxin was a research drug prior to its attaining FDA approval.
Drs. Perman and Cytryn have taught numerous physicians, both in the U.S. and abroad in the
techniques of neurotoxin injections. Patients seek out our expertise for treatment of facial
What is XEOMIN?
XEOMIN is a botulinum toxin that is used to treat adults
with cervical dystonia and blepharospasm. It has been used around the world since 2005 and was
introduced to the US market in 2010 by Merz Pharmaceuticals, LLC.
·To treat adults
with cervical dystonia to decrease the severity of abnormal head position and neck pain
·To treat abnormal spasm
of the eyelids (blepharospasm) in adults who have had prior treatment with onabotulinumtoxinA
Botulinum toxin is a naturally occurring protein produced by the bacteria
Clostridium botulinum. Botulinum toxin type A—the active ingredient in XEOMIN—is
produced commercially from C. botulinum serotype A.
XEOMIN is injected into muscles to decrease their activity.
XEOMIN blocks the release of a chemical messenger—acetylcholine—that conveys the
signal from nerve terminals and causes muscle fibers to contract. Not all terminals
are affected by botulinum toxin, so the muscles can still contract, just less
forcefully. This allows the muscles to contract more
Not all botulinum toxin products are the same. This is reflected in the unique names
for each product. The dose of XEOMIN may be different from other botulinum toxin
In nature, C. botulinum produces the toxin in association with accessory proteins
(toxin complex). Merz takes the toxin complex and employs a proprietary manufacturing process
that isolates the therapeutic component and removes the accessory proteins to produce